Trial Profile
Dose-adjusted alemtuzumab induction regimen in renal transplantation
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 19 Aug 2015 New trial record